BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23657977)

  • 1. Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: diagnostic considerations for mucopolysaccharidoses.
    Mendelsohn NJ; Wood T; Olson RA; Temme R; Hale S; Zhang H; Read L; White KK
    JIMD Rep; 2013; 11():125-32. PubMed ID: 23657977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI].
    Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
    Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
    Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis VI.
    Valayannopoulos V; Nicely H; Harmatz P; Turbeville S
    Orphanet J Rare Dis; 2010 Apr; 5():5. PubMed ID: 20385007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose.
    Lachman RS; Burton BK; Clarke LA; Hoffinger S; Ikegawa S; Jin DK; Kano H; Kim OH; Lampe C; Mendelsohn NJ; Shediac R; Tanpaiboon P; White KK
    Skeletal Radiol; 2014 Mar; 43(3):359-69. PubMed ID: 24389823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re-evaluating primer sequences.
    Kim SM; Noh ES; Park JH; Park HD; Lee SY; Jang JH; Cho SY
    Ann Hum Genet; 2022 Nov; 86(6):361-368. PubMed ID: 36000290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
    Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
    Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteroallelic missense mutations of the galactosamine-6-sulfate sulfatase (GALNS) gene in a mild form of Morquio disease (MPS IVA).
    Cole DE; Fukuda S; Gordon BA; Rip JW; LeCouteur AN; Rupar CA; Tomatsu S; Ogawa T; Sukegawa K; Orii T
    Am J Med Genet; 1996 Jun; 63(4):558-65. PubMed ID: 8826435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing mucopolysaccharidosis IVA.
    Wood TC; Harvey K; Beck M; Burin MG; Chien YH; Church HJ; D'Almeida V; van Diggelen OP; Fietz M; Giugliani R; Harmatz P; Hawley SM; Hwu WL; Ketteridge D; Lukacs Z; Miller N; Pasquali M; Schenone A; Thompson JN; Tylee K; Yu C; Hendriksz CJ
    J Inherit Metab Dis; 2013 Mar; 36(2):293-307. PubMed ID: 23371450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots.
    Ullal AJ; Millington DS; Bali DS
    Mol Genet Metab Rep; 2014; 1():461-464. PubMed ID: 27896123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
    Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
    Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroitin sulfate and growth factor signaling in the skeleton: Possible links to MPS VI.
    Alliston T
    J Pediatr Rehabil Med; 2010; 3(2):129-38. PubMed ID: 20628554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative profile exhibited by Mucopolysaccharidosis type IVA patients at diagnosis: Increased keratan urinary levels.
    Donida B; Marchetti DP; Jacques CED; Ribas G; Deon M; Manini P; da Rosa HT; Moura DJ; Saffi J; Giugliani R; Vargas CR
    Mol Genet Metab Rep; 2017 Jun; 11():46-53. PubMed ID: 28487826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in ARSB in MPS VI patients in India.
    Mathew J; Jagadeesh SM; Bhat M; Udhaya Kumar S; Thiyagarajan S; Srinivasan S
    Mol Genet Metab Rep; 2015 Sep; 4():53-61. PubMed ID: 26937411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bio-Plex immunoassay measuring the quantity of lysosomal
    Chuang CK; Lin HY; Wang TJ; Huang SF; Lin SP
    BMJ Open; 2017 Jul; 7(7):e014410. PubMed ID: 28710204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
    Harmatz P; Hendriksz CJ; Lampe C; McGill JJ; Parini R; Leão-Teles E; Valayannopoulos V; Cole TJ; Matousek R; Graham S; Guffon N; Quartel A;
    Mol Genet Metab; 2017 Sep; 122(1-2):107-112. PubMed ID: 28457718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment.
    Harmatz P; Shediac R
    Front Biosci (Landmark Ed); 2017 Jan; 22(3):385-406. PubMed ID: 27814620
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.